Autolus Therapeutics to host Investor Conference Calls through June
1 June 2020 - Dr.Christian Itin , chairman and chief executive officer, along with the AUTO3 clinical team, will host an investor call and webcast at8.30 am EDT ,1.30 pm BST to discuss presentations related to its AUTO3 program, the company’s CAR T cell therapy being investigated in the Alexander study, a Phase 1/2 study in relapsed/refractory diffuse large B cell lymphoma (DLBCL), during the AnnualSociety of Clinical Oncology 2020 (ASCO20) Virtual Scientific Program. After the conference call, a replay will be available for one week.
4 June 2020 - Dr. Christian Itin, chairman and chief executive officer, will participate in a fireside chat at theJefferies Global Healthcare Conference at8.30 am EDT ,1.30 pm BST and will also host virtual one-on-one meetings. A live audio webcast of the fireside chat will be available on the investor relations section of Autolus’ website at https://www.autolus.com. An archived replay will be available on the company’s website for a period of 90 days after the conference.10 June 2020 - Dr. Christian Itin, chairman and chief executive officer, will participate in a fireside chat at theGoldman Sachs Healthcare Conference at09.40 am EDT ,2.40 pm BST on 10 June. A live audio webcast of the fireside chat will be available on the investor relations section of Autolus’ website at https://www.autolus.com. An archived replay will be available on the company’s website for a period of 90 days after the conference.
15 June 2020 - Dr.Christian Itin , chairman and chief executive officer, along with theAUTO1 and AUTO3 clinical teams, will host an investor call and webcast at8.30 am EDT ,1.30 pm BST to discuss presentations related to itsAUTO1 and AUTO3 programs, the company’s CAR T cell therapies being investigated in Phase 1/2 studies of adult Acute Lymphocytic Leukemia (ALL) and relapsed/refractory Diffuse Large B Cell Lymphoma (DLBCL), respectively, at theEuropean Hematology Association EHA25 Virtual Congress onJune 11 – 14, 2020. After the conference call, a replay will be available for one week.
25 June 2020 - Dr.Christian Itin , chairman and chief executive officer, along with the AUTO5, AUTO6NG and AUTO7 clinical teams, will host an investor call and webcast at8.30 am EDT ,1.30 pm BST to discuss presentations related to its next-generation programmed T cell therapies in T cell lymphoma, small cell lung cancer and prostate cancer, respectively, at theAmerican Association for Cancer Research (AACR) Virtual Annual Meeting II onJun 22 - 24, 2020 . After the conference call, a replay will be available for one week.
About
Contact:
Vice President, Investor Relations and Corporate Communications
+44 (0) 7587 372 619
l.crabtree@autolus.com
+44 (0) 7818 430877
j.wilson@autolus.com
+1-212-966-3650
susan@sanoonan.com
Source: Autolus Therapeutics plc